Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Hamilton Thorne's share price for the quarter that ended in Sep. 2024 was $1.625. Hamilton Thorne's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 154.13 Mil. Therefore, Hamilton Thorne's market cap for the quarter that ended in Sep. 2024 was $250.46 Mil.
Hamilton Thorne's quarterly market cap
increased
from Mar. 2024 ($151.54 Mil) to Jun. 2024 ($163.37 Mil) and
increased
from Jun. 2024 ($163.37 Mil) to Sep. 2024 ($250.46 Mil).
Hamilton Thorne's annual market cap
declined
from Dec. 2021 ($225.22 Mil) to Dec. 2022 ($172.35 Mil) and
declined
from Dec. 2022 ($172.35 Mil) to Dec. 2023 ($153.65 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Hamilton Thorne's Enterprise Value for Today is $264.82 Mil.
Hamilton Thorne Market Cap Historical Data
The historical data trend for Hamilton Thorne's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Hamilton Thorne's Market Cap
For the Medical Devices subindustry, Hamilton Thorne's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hamilton Thorne's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hamilton Thorne's Market Cap distribution charts can be found below:
* The bar in red indicates where Hamilton Thorne's Market Cap falls into.
Hamilton Thorne Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Hamilton Thorne's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hamilton Thorne (OTCPK:HTLZF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Hamilton Thorne Market Cap Related Terms
Thank you for viewing the detailed overview of Hamilton Thorne's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Hamilton Thorne Ltd is engaged in providing precision instruments, consumables, software, and services that reduce cost, increase productivity, improve results, and enable breakthroughs in Assisted Reproductive Technologies (ART), research, and cell biology markets. The company markets its products and services under the Hamilton Thorne, Gynemed, and Embryotech Laboratories brands, through its growing sales force and distributors. The company's customer base consists of fertility clinics, university research centers, animal breeding facilities, pharmaceutical companies, biotechnology companies, and other commercial and academic research establishments. It has a single reporting segment being Engaged in Sales to the ART, Research, and Cell Biology Markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HTLZF has been successfully added to your 